Literature DB >> 21357546

The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis.

Brian R Lindman1, Suzanne V Arnold, José A Madrazo, Alan Zajarias, Stephanie N Johnson, Julio E Pérez, Douglas L Mann.   

Abstract

BACKGROUND: The diabetic heart exhibits increased left ventricular (LV) mass and reduced ventricular function. However, this relationship has not been studied in patients with aortic stenosis (AS), a disease process that causes LV hypertrophy and dysfunction through a distinct mechanism of pressure overload. The aim of this study was to determine how diabetes mellitus (DM) affects LV remodeling and function in patients with severe AS. METHODS AND
RESULTS: Echocardiography was performed on 114 patients with severe AS (mean aortic valve area [AVA], 0.6 cm(2)) and included measures of LV remodeling and function. Multivariable linear regression models investigated the independent effect of DM on these aspects of LV structure and function. Compared to patients without diabetes (n=60), those with diabetes (n=54) had increased LV mass and LV end-systolic and end-diastolic dimensions, and decreased LV ejection fraction (EF) and longitudinal systolic strain (all P<0.01). In multivariable analyses adjusting for age, sex, systolic blood pressure, AVA, body surface area, and coronary disease, DM was an independent predictor of increased LV mass (β=26 g, P=0.01), LV end-systolic dimension (β=0.5 cm, P=0.008), and LV end-diastolic dimension (β=0.3 cm, P=0.025). After also adjusting for LV mass, DM was associated with reduced longitudinal systolic strain (β=1.9%, P=0.023) and a trend toward reduced EF (β=-5%, P=0.09). Among patients with diabetes, insulin use (as a marker of disease severity) was associated with larger LV end-systolic dimension and worse LV function. LV mass was a strong predictor of reduced EF and systolic strain (both P<0.001).
CONCLUSIONS: DM has an additive adverse effect on hypertrophic remodeling (increased LV mass and larger cavity dimensions) and is associated with reduced systolic function in patients with AS beyond known factors of pressure overload.

Entities:  

Mesh:

Year:  2011        PMID: 21357546      PMCID: PMC3100796          DOI: 10.1161/CIRCHEARTFAILURE.110.960039

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  29 in total

1.  Left ventricular mass index in aortic valve surgery: a new index for early valve replacement?

Authors:  Rafael García Fuster; José A Montero Argudo; Oscar Gil Albarova; Fernando Hornero Sos; Sergio Cánovas López; Ma José Dalmau Sorlí; María Bueno Codoñer; José A Buendía Miñano
Journal:  Eur J Cardiothorac Surg       Date:  2003-05       Impact factor: 4.191

2.  Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study).

Authors:  J N Bella; R B Devereux; M J Roman; V Palmieri; J E Liu; M Paranicas; T K Welty; E T Lee; R R Fabsitz; B V Howard
Journal:  Am J Cardiol       Date:  2001-06-01       Impact factor: 2.778

3.  Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study.

Authors:  V Palmieri; J N Bella; D K Arnett; J E Liu; A Oberman; M Y Schuck; D W Kitzman; P N Hopkins; D Morgan; D C Rao; R B Devereux
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

Review 4.  Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus.

Authors:  K H Mak; E J Topol
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

5.  Impact of diabetes on cardiac structure and function: the strong heart study.

Authors:  R B Devereux; M J Roman; M Paranicas; M J O'Grady; E T Lee; T K Welty; R R Fabsitz; D Robbins; E R Rhoades; B V Howard
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

6.  Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin).

Authors:  Anik Pagé; Jean G Dumesnil; Marie-Annick Clavel; Kwan L Chan; Koon K Teo; James W Tam; Patrick Mathieu; Jean-Pierre Després; Philippe Pibarot
Journal:  J Am Coll Cardiol       Date:  2010-04-27       Impact factor: 24.094

7.  Does diabetes accelerate progression of calcific aortic stenosis?

Authors:  Masoor Kamalesh; Charlotte Ng; Hicham El Masry; George Eckert; Stephen Sawada
Journal:  Eur J Echocardiogr       Date:  2009-04-30

8.  Survival after valve replacement for aortic stenosis: implications for decision making.

Authors:  Tomislav Mihaljevic; Edward R Nowicki; Jeevanantham Rajeswaran; Eugene H Blackstone; Luigi Lagazzi; James Thomas; Bruce W Lytle; Delos M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  2008-05-23       Impact factor: 5.209

9.  A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload.

Authors:  Michael J Raher; Helene B Thibault; Emmanuel S Buys; Darshini Kuruppu; Nobuyuki Shimizu; Anna-Liisa Brownell; Sarah L Blake; Jennifer Rieusset; Masao Kaneki; Genevieve Derumeaux; Michael H Picard; Kenneth D Bloch; Marielle Scherrer-Crosbie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

10.  Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes.

Authors:  Ralica Petrova; Yasuhiko Yamamoto; Katsuhiko Muraki; Hideto Yonekura; Shigeru Sakurai; Takuo Watanabe; Hui Li; Masayoshi Takeuchi; Zenji Makita; Ichiro Kato; Shin Takasawa; Hiroshi Okamoto; Yuji Imaizumi; Hiroshi Yamamoto
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

View more
  20 in total

1.  LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.

Authors:  Khiet Hoang; Yanglu Zhao; Julius M Gardin; Mercedes Carnethon; Ken Mukamal; David Yanez; Nathan D Wong
Journal:  JACC Cardiovasc Imaging       Date:  2015-08-26

2.  Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.

Authors:  Brian R Lindman; Jared G Breyley; Joel D Schilling; Anna M Vatterott; Alan Zajarias; Hersh S Maniar; Ralph J Damiano; Marc R Moon; Jennifer S Lawton; Brian F Gage; Marc A Sintek; Alejandro Aquino; Christopher L Holley; Neil M Patel; Cassandra Lawler; John M Lasala; Eric Novak
Journal:  Heart       Date:  2015-06-02       Impact factor: 5.994

3.  Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis.

Authors:  Brian R Lindman; Alan Zajarias; José A Madrazo; Jay Shah; Brian F Gage; Eric Novak; Stephanie N Johnson; Murali M Chakinala; Tara A Hohn; Mohammed Saghir; Douglas L Mann
Journal:  Circulation       Date:  2012-03-25       Impact factor: 29.690

Review 4.  Severe and Asymptomatic Aortic Stenosis Management Challenge: Knowing That We Do Not Really Know.

Authors:  Lionel Tastet; Louis Simard; Marie-Annick Clavel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

Review 5.  Diabetes and the risk of heart failure.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Heart Fail Clin       Date:  2011-10-13       Impact factor: 3.179

Review 6.  Current management of calcific aortic stenosis.

Authors:  Brian R Lindman; Robert O Bonow; Catherine M Otto
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

Review 7.  Diabetes mellitus is associated with increased acute kidney injury and 1-year mortality after transcatheter aortic valve replacement: A meta-analysis.

Authors:  George S Mina; Priyanka Gill; Demiana Soliman; Pratap Reddy; Paari Dominic
Journal:  Clin Cardiol       Date:  2017-05-16       Impact factor: 2.882

Review 8.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

9.  Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve).

Authors:  Brian R Lindman; Philippe Pibarot; Suzanne V Arnold; Rakesh M Suri; Thomas C McAndrew; Hersh S Maniar; Alan Zajarias; Susheel Kodali; Ajay J Kirtane; Vinod H Thourani; E Murat Tuzcu; Lars G Svensson; Ron Waksman; Craig R Smith; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

Review 10.  Calcific aortic stenosis.

Authors:  Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot
Journal:  Nat Rev Dis Primers       Date:  2016-03-03       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.